MP53-20 ADDED VALUE OF MPMRI IN THE STRATIFICATION OF PATIENTS WITH HIGH-RISK PATIENTS PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: IMPLICATIONS FOR TAILORED MULTI-MODAL STRATEGIES. (May 2022)